The target trial emulation study suggests rigid risk thresholds aren’t needed to steer statin use in this group.

Findings of reduced risks for mortality and major CVD suggest consideration of statins in all adults with type 2 diabetes, even in those with low short-term predicted CVD risk.

Statins, which are used in treating heart disease, are among the most widely prescribed medications in the U.S. Diabetes is associated with a very high risk of heart disease. So the thinking has been ...

A large cohort study found that statins significantly reduce the risk of death and major cardiovascular events in adults with ...

Please provide your email address to receive an email when new articles are posted on . “Statins, the most employed intervention to improve [cardiovascular disease (CVD)] outcomes in the general ...

March 31, 2011 (San Francisco) — A new analysis of three major trials with atorvastatin (Lipitor, Pfizer) has suggested that the risk of new-onset diabetes with statins appears to be dose dependent ...

Statins are under-prescribed in patients with type 2 diabetes who are receiving anti-hyperglycemic agents, according to an analysis of medical records from a large database. The results show that ...

NEW YORK (Reuters Health) - People with heart problems who were started on cholesterol-lowering statins were more likely to develop diabetes if they were prescribed stronger versions of the drugs, a ...

High doses of cholesterol-lowering drugs called statins may protect patients from heart attack, but a new analysis of five previous clinical trials finds that they may also increase patients’ risk of ...

Statin therapy demonstrated a dose-dependent increase in the risk for new-onset diabetes, especially among individuals already at high risk for diabetes. Higher doses of statin therapy moderately ...

Please provide your email address to receive an email when new articles are posted on . The benefits of statin use to prevent cardiovascular disease and mortality in patients with rheumatoid arthritis ...

(Reuters) - Cholesterol-lowering drugs known as statins may be linked to an increased risk of diabetes in middle-aged and older women, according to a U.S. study -- but researchers said the benefits of ...